128 related articles for article (PubMed ID: 2571386)
41. Desensitization to sulphasalazine in patients with arthritis.
Koski JM
Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
[TBL] [Abstract][Full Text] [Related]
42. Bone marrow IgA and IgA subclass synthesis in ankylosing spondylitis.
Peeters AJ; Daha MR; Smeets TJ; Breedveld FC
J Rheumatol; 1992 May; 19(5):751-3. PubMed ID: 1613704
[TBL] [Abstract][Full Text] [Related]
43. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR
Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302
[TBL] [Abstract][Full Text] [Related]
44. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up.
Lehtinen A; Leirisalo-Repo M; Taavitsainen M
Clin Exp Rheumatol; 1995; 13(6):733-6. PubMed ID: 8835246
[TBL] [Abstract][Full Text] [Related]
45. Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapy.
Hammoudeh M; Zack DJ; Li W; Stewart VM; Koenig AS
J Int Med Res; 2013 Aug; 41(4):1150-9. PubMed ID: 23803306
[TBL] [Abstract][Full Text] [Related]
46. Sulfasalazine for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
[TBL] [Abstract][Full Text] [Related]
47. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
[No Abstract] [Full Text] [Related]
48. Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes.
Peeters AJ; van den Wall Bake AW; van Dalsen AD; Westedt ML
Ann Rheum Dis; 1988 Aug; 47(8):645-7. PubMed ID: 3415363
[TBL] [Abstract][Full Text] [Related]
49. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
[TBL] [Abstract][Full Text] [Related]
50. [A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis].
Huang F; Zhang J; Zheng Y; Xu JH; Li XF; Wu HX; Chen ZW; Zhao Z; Zhang YM
Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1043-7. PubMed ID: 22333175
[TBL] [Abstract][Full Text] [Related]
51. Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial.
Wang Y; Xiao X
Med Sci Monit; 2018 May; 24():2912-2918. PubMed ID: 29735967
[TBL] [Abstract][Full Text] [Related]
52. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
van der Heijde D; Da Silva JC; Dougados M; Geher P; van der Horst-Bruinsma I; Juanola X; Olivieri I; Raeman F; Settas L; Sieper J; Szechinski J; Walker D; Boussuge MP; Wajdula JS; Paolozzi L; Fatenejad S;
Ann Rheum Dis; 2006 Dec; 65(12):1572-7. PubMed ID: 16968715
[TBL] [Abstract][Full Text] [Related]
53. Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial.
Steven MM; Morrison M; Sturrock RD
J Rheumatol; 1985 Aug; 12(4):735-7. PubMed ID: 3903158
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
van der Heijde D; Kivitz A; Schiff MH; Sieper J; Dijkmans BA; Braun J; Dougados M; Reveille JD; Wong RL; Kupper H; Davis JC;
Arthritis Rheum; 2006 Jul; 54(7):2136-46. PubMed ID: 16802350
[TBL] [Abstract][Full Text] [Related]
55. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.
Sanders KM; Hertzman A; Escobar MR; Littman BH
Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781
[TBL] [Abstract][Full Text] [Related]
56. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.
Franssen MJ; van de Putte LB; Gribnau FW
Ann Rheum Dis; 1985 Nov; 44(11):766-71. PubMed ID: 4062389
[TBL] [Abstract][Full Text] [Related]
57. Association of inflammation with raised serum IgA in ankylosing spondylitis.
Cowling P; Ebringer R; Ebringer A
Ann Rheum Dis; 1980 Dec; 39(6):545-9. PubMed ID: 7458430
[TBL] [Abstract][Full Text] [Related]
58. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
59. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM
Ann Rheum Dis; 1992 Aug; 51(8):946-50. PubMed ID: 1358037
[TBL] [Abstract][Full Text] [Related]
60. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
Huang JL; Hung IJ; Hsieh KH
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):71-5. PubMed ID: 9346269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
